Association of Dysfunction of Vascular Access for Hemodialysis With Major Adverse Cardiovascular Events - A

Te-Hui Kuo1,2, Chin-Li Lu3, Ya-Hui Chang2

  • 1Division of Nephrology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University.

Insights

Persistent dysfunction of hemodialysis vascular access significantly increases the risk of major adverse cardiovascular events (MACE). This finding aids in identifying high-risk patients for better cardiovascular event prevention in dialysis care.

Area of Science:

  • Nephrology
  • Cardiology
  • Clinical Epidemiology

Background:

  • Vascular access dysfunction is an unconventional risk factor for major adverse cardiovascular events (MACE) in hemodialysis patients.
  • Previous studies identified this association, but clinical application requires intuitive risk stratification.
  • Group-based trajectory modeling was employed to identify patients at highest risk for MACE.

Purpose of the Study:

  • To identify and categorize hemodialysis patients based on vascular access dysfunction trajectories.
  • To determine the association between different dysfunction patterns and the risk of subsequent MACE.

Main Methods:

  • A cohort of 9,711 hemodialysis patients with MACE and 19,422 matched controls (2001-2010) were analyzed.
  • Vascular access dysfunction events in the 6 months prior to MACE or index dates were evaluated.
  • Group-based trajectory modeling categorized patients into no, escalating, or persistent dysfunction groups.

Main Results:

  • Three patient groups were identified: no dysfunction (n=26,744), escalating dysfunction (n=650), and persistent dysfunction (n=1,739).
  • Patients with persistent vascular access dysfunction (group 3) exhibited the highest risk of subsequent MACE.
  • Logistic regression showed an odds ratio of 2.47 for MACE in group 3 compared to group 1, after adjusting for confounders.

Conclusions:

  • Uninterrupted or persistent clusters of vascular access dysfunction are significantly associated with an elevated risk of subsequent MACE in hemodialysis patients.
  • This trajectory-based approach offers a more intuitive method for identifying high-risk individuals for MACE.
  • Targeting vascular access dysfunction management may be crucial for cardiovascular event prevention in dialysis populations.
Abstract

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
982
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
448
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
603
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
587
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
350
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.9K